This is not the most recent version of the article. View current version (20 MAR 2015)

Intervention Protocol

You have free access to this content

Add-back therapy with GnRH analogues for uterine fibroids

  1. Rafael M Moroni,
  2. Wellington P Martins,
  3. Rui A Ferriani,
  4. Carolina S Vieira,
  5. Carolina O Nastri,
  6. Francisco José Candido Dos Reis,
  7. Luiz Gustavo Brito*

Editorial Group: Cochrane Menstrual Disorders and Subfertility Group

Published Online: 5 DEC 2013

DOI: 10.1002/14651858.CD010854

How to Cite

Moroni RM, Martins WP, Ferriani RA, Vieira CS, Nastri CO, Candido Dos Reis FJ, Brito LG. Add-back therapy with GnRH analogues for uterine fibroids (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD010854. DOI: 10.1002/14651858.CD010854.

Author Information

  1. University of Sao Paulo, Department of Obstetrics and Gynecology, Medical School of Ribeirao Preto, Ribeirao Preto, Brazil

*Luiz Gustavo Brito, Department of Obstetrics and Gynecology, Medical School of Ribeirao Preto, University of Sao Paulo, Avenida Bandeirantes, 3900, 8th floor ? Monte Alegre Ribeirao Preto, Ribeirao Preto, 14049-900, Brazil.

Publication History

  1. Publication Status: New
  2. Published Online: 5 DEC 2013


This is not the most recent version of the article. View current version (20 MAR 2015)


Additional references

Borgfeldt 2000
  • Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25–40 years. Acta Obstetricia et Gynecologica Scandinavica 2000;79(3):202-7.
Bozzini 2004
  • Bozzini N, Messina ML, Borsari R, Hilário SG, Pinotti JA. Comparative study of different dosages of goserelin in size reduction of myomatous uteri. The Journal of the American Association of Gynecologic Laparoscopists 2004;11:462-63.
Caird 1997
  • Caird LE, West CP, Lumsden MA, Hannan WJ, Gow SM. Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability. Human Reproduction 1997;12(3):436-40.
Cheung 2011
  • Cheung W, Borawski D. Lower tract urinary symptoms in patients with uterine myomas. International Urogynecology Journal and Pelvic Floor Dysfunction 2011;22(Suppl 2):1309-10.
Cohen 1988
  • Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Erlbaum Associates, 1988.
Costantini 1990
  • Costantini S, Anserini P, Valenzano M, Remorgida V, Venturini PL, De Cecco L. Luteinizing hormone-releasing hormone analogue therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot. European Journal of Obstetrics & Gynecology and Reproductive Biology 1990;37(1):63-9.
Day Baird 2003
  • Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. American Journal of Obstetrics and Gynecology 2003;188:100-7.
Flake 2002
Friedman 1987
  • Friedman AJ, Barbieri RL, Benacerraf BR, Schiff I. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist. Fertility and Sterility 1987;48(4):560-4.
Friedman 1991
  • Friedman, AJ, Hoffman, DI, Comite, F, Browneller RW, Miller, JD. Treatment of leiomyomata uteri with leuprolide acetate depot: A double-blind, placebo-controlled, multicenter study.. Obstetrics and Gynecology 1991;77(5):720-25.
Gocmen 2002
  • Gocmen A, Kara IH, Karaca M. The effects of add-back therapy with tibolone on myoma uteri. Clinical and Experimental Obstetrics and Gynecology 2002;29(3):222-4.
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from
Higham 1990
Islam 2013
  • Islam MS, Protic O, Giannubilo SR, Toti P, Tranquilli AL, Petraglia F, et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options. The Journal of Clinical Endocrinology & Metabolism 2013;98(3):921-34.
Lippman 2003
  • Lippman SA, Warner M, Samuels S, Olive D, Vercellini P, Eskenazi B. Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertility and Sterility 2003;80:1488-94.
Lumsden 1998
Palomba 2002
  • Palomba S, Russo T, Orio F Jr, Tauchmanovà L, Zupi E, Panici PL, et al. Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomised, single-blind, placebo-controlled clinical trial. Human Reproduction 2002;17(12):3213-9.
Perry 1996
Sankaran 2008
Schlaff 1989
  • Schlaff WD, Zerhouni EA, Huth JA, Chen J, Damewood MD, Rock JA. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata. Obstetrics and Gynecology 1989;74(6):856-62.
Shaw 1972
Sunkara 2010
  • Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomarasamy A. The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis. Human Reproduction 2010;25(2):418-29.
Wegienka 2003
  • Wegienka G, Baird DD, Hertz-Picciotto I, Harlow SD, Steege JF, Hill MC. Self-reported heavy bleeding associated with uterine leiomyomata. Obstetrics and Gynecology 2003;101:431-7.
Williams 1990
  • Williams IA, Shaw RW. Effect of nafarelin on uterine fibroids measured by ultrasound and magnetic resonance imaging. European Journal of Obstetrics, Gynecology and Reproductive Biology 1990;34:111-17.